Literature DB >> 2458086

Changes in the influenza virus haemagglutinin at acid pH detected by monoclonal antibodies to glycopolypeptides HA1 and HA2.

F Kostolansky1, G Russ, V Mucha, B Styk.   

Abstract

Monoclonal antibodies (Mabs) specific to the HA1 and HA2 subunits of the influenza virus haemagglutinin (HA) were used to show that changes in the antigenicity of the HA molecule at acid pH involve both HA subunits. In solid phase RIA (intact virus adsorbed) the acid-induced change was detected in the form of greatly increased binding of anti-HA 1 Mabs (IVA 1 and IVG 6) and anti-HA2 Mab (IIF 4). This increased binding could be most probably explained by alterations in accessibility of epitopes to the corresponding Mabs. Other Mabs examined (including 7 anti-HA2 Mabs specific to 3 independent antigenic sites) had either similar reactivities with both untreated and pH 5-treated virus or slightly but significantly increased binding to pH 5-treated virus. No effect of pH 5 treatment on antibody binding was observed with purified BHA in solid phase RIA. Nevertheless a similar pH 5-induced conformational change in the isolated BHA (like in intact viral HA in solid phase RIA) was detected in competitive binding assay carried out in liquid phase.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2458086     DOI: 10.1007/bf01314648

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  21 in total

1.  Conformational changes in influenza virus haemagglutinin and its monomer detected by monoclonal antibodies.

Authors:  A N Nestorowicz; D O White; D C Jackson
Journal:  Vaccine       Date:  1985-09       Impact factor: 3.641

2.  Antigenic determinants of influenza virus haemagglutinin. X. A comparison of the physical and antigenic properties of monomeric and trimeric forms.

Authors:  A Nestorowicz; G Laver; D C Jackson
Journal:  J Gen Virol       Date:  1985-08       Impact factor: 3.891

3.  Antigenic glycopolypeptides HA1 and HA2 of influenza virus haemagglutinin. I. Gel filtration in 6 M guanidine hydrochloride.

Authors:  K Poláková; G Russ; B Styk
Journal:  Acta Virol       Date:  1978-09       Impact factor: 1.162

4.  Antigenic glycopolypeptides HA1 and HA2 of influenza virus haemagglutinin. IV. Immunogenic properties of separated haemagglutinin glycopolypeptides.

Authors:  B Styk; G Russ; K Poláková
Journal:  Acta Virol       Date:  1979-01       Impact factor: 1.162

5.  Monoclonal anti-hemagglutinin antibodies detect irreversible antigenic alterations that coincide with the acid activation of influenza virus A/PR/834-mediated hemolysis.

Authors:  J W Yewdell; W Gerhard; T Bachi
Journal:  J Virol       Date:  1983-10       Impact factor: 5.103

6.  Monoclonal antibodies to glycopolypeptides HA1 and HA2 of influenza virus haemagglutinin.

Authors:  G Russ; K Poláková; F Kostolanský; B Styk; M Vancíková
Journal:  Acta Virol       Date:  1987-09       Impact factor: 1.162

7.  Production and characterization of monoclonal antibodies against avian myeloblastosis virus.

Authors:  K Poláková; G Russ
Journal:  Neoplasma       Date:  1983       Impact factor: 2.575

8.  Membrane binding and conformational properties of peptides representing the NH2 terminus of influenza HA-2.

Authors:  J D Lear; W F DeGrado
Journal:  J Biol Chem       Date:  1987-05-15       Impact factor: 5.157

9.  Antigenic and biological characterization of influenza virus neuraminidase (N2) with monoclonal antibodies.

Authors:  R G Webster; L E Brown; W G Laver
Journal:  Virology       Date:  1984-05       Impact factor: 3.616

10.  Assembly of influenza hemagglutinin trimers and its role in intracellular transport.

Authors:  C S Copeland; R W Doms; E M Bolzau; R G Webster; A Helenius
Journal:  J Cell Biol       Date:  1986-10       Impact factor: 10.539

View more
  5 in total

1.  Monoclonal antibodies demonstrate accessible HA2 epitopes in minor subpopulation of native influenza virus haemagglutinin molecules.

Authors:  E Varecková; V Mucha; F Ciampor; T Betáková; G Russ
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

2.  Immunogenicity of low-pH treated whole viral influenza vaccine.

Authors:  Fu-Shi Quan; Zhu-Nan Li; Min-Chul Kim; Dan Yang; Richard W Compans; David A Steinhauer; Sang-Moo Kang
Journal:  Virology       Date:  2011-06-30       Impact factor: 3.616

3.  Thiol/disulfide exchange is required for membrane fusion directed by the Newcastle disease virus fusion protein.

Authors:  Surbhi Jain; Lori W McGinnes; Trudy G Morrison
Journal:  J Virol       Date:  2006-12-06       Impact factor: 5.103

4.  Evaluation of monoclonal antibodies for subtyping of currently circulating human type A influenza viruses.

Authors:  M Tkácová; E Varecková; I C Baker; J M Love; T Ziegler
Journal:  J Clin Microbiol       Date:  1997-05       Impact factor: 5.948

Review 5.  Virus-like particles as universal influenza vaccines.

Authors:  Sang-Moo Kang; Min-Chul Kim; Richard W Compans
Journal:  Expert Rev Vaccines       Date:  2012-08       Impact factor: 5.217

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.